Tech Company Financing Transactions
Providence Medical Technology Funding Round
Providence Medical Technology, based in Pleasanton, received $6.8 million from Stanmore Medical Investments, Aphelion Capital and RCT BioVentures.
Transaction Overview
Company Name
Announced On
4/1/2014
Transaction Type
Venture Equity
Amount
$6,800,000
Round
Series C
Investors
Stanmore Medical Investments (Lead Investor) (David Cash)
Aphelion Capital (Ned Scheetz)
Proceeds Purpose
Proceeds from this round are targeted to fund investment in U.S. sales, marketing, training, and clinical activities, including training additional distributors, hiring direct sales employees, and initiating prospective clinical trials.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3875 Hopyard Rd. 300
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
A privately-held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market. Commercializing the DTRAX platform of minimally invasive posterior cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression and stabilization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Smith
Chief Operating Officer
Edward Liou
Vice President
Michael Scott
VP - Marketing
Scott Lynch
VP - R & D
Shigeru Tanaka
VP - Regulatory Affairs
Janie Mandrusov
VP - Sales
Jeremy Laynor
Browse more venture capital transactions:
Prev: 4/1/2014: Neurovance venture capital transaction
Next: 4/2/2014: WalkMe venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs